ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Psychiatry

Top Psychiatry Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FRANCISCO RICART MD

Psychiatry

16,746

$4.11M

872
650 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 25%

$245
Average prescription price

Avg: $113

FRANCISCO PAGES M.D.

Psychiatry

14,925

$2.95M

1006
576 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 25%

$198
Average prescription price

Avg: $113

BERNARDO PASCUAL M.D.

Psychiatry

13,785

$2.32M

625
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 25%

$168
Average prescription price

Avg: $113

BARRY KAPLOWITZ M.D.

Psychiatry

13,240

$2.27M

808
466 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

1%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$172
Average prescription price

Avg: $113

ANTONIO TAULER MD

Psychiatry

13,375

$2.08M

739
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 25%

$155
Average prescription price

Avg: $113

FERNANDO MENDEZ-VILLAMIL M.D.

Psychiatry

16,052

$2.05M

991
429 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $113

ENRIQUE CASUSO M.D.

Psychiatry

21,690

$1.98M

1440
1044 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$91
Average prescription price

Avg: $113

LUIS GUERRERO MD

Psychiatry

16,240

$1.72M

746
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$106
Average prescription price

Avg: $113

JOSE GAMEZ M.D

Psychiatry

10,755

$1.67M

660
395 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 25%

$155
Average prescription price

Avg: $113

LINDA LEFLER MD

Psychiatry

10,914

$1.63M

639
69 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$149
Average prescription price

Avg: $113

EMILIO MANTERO ATIENZA MD

Psychiatry

8,773

$1.6M

537
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 25%

$183
Average prescription price

Avg: $113

JORGE BENITO MD

Psychiatry

13,683

$1.58M

899
627 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $113

NELSON HERNANDEZ MD

Psychiatry

12,695

$1.49M

1050
581 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$117
Average prescription price

Avg: $113

GUY CZAYKOWSKY M.D.

Psychiatry

6,341

$1.49M

302
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$235
Average prescription price

Avg: $113

TODD GATES D.O.

Psychiatry

11,432

$1.39M

489
73 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$122
Average prescription price

Avg: $113

SILVIA SILVA DULUC M.D.

Psychiatry

12,619

$1.38M

841
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $113

ALFREDO PINIELLA M.D.

Psychiatry

8,348

$1.33M

496
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 25%

$160
Average prescription price

Avg: $113

JAMES LARSON MD

Psychiatry

7,994

$1.32M

467
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$165
Average prescription price

Avg: $113

MICHAEL VANDEWALLE D.O.

Psychiatry

10,396

$1.23M

823
123 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $113

CARLOS PEREZ M.D.

Psychiatry

9,882

$1.2M

1219
986 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $113

ALFREDO PUJOL M.D.

Psychiatry

6,680

$1.15M

555
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 25%

$171
Average prescription price

Avg: $113

UMESH MHATRE M.D.

Psychiatry

8,939

$1.12M

739
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $113

RIFFAT QURESHI M.D.

Psychiatry

9,474

$1.1M

632
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $113

HAMLET HASSAN MD

Psychiatry

9,783

$1.09M

778
636 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $113

JUNIOR PITTACK MD

Psychiatry

6,253

$1.08M

388
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 25%

$173
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank